Drug profile · INN
lonoctocog alfa
AFSTYLA
lonoctocog alfa (AFSTYLA) is a coagulation factor viii exogenous protein.
EMA: approved PMDA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lonoctocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
lonoctocog alfa (AFSTYLA) is a coagulation factor viii exogenous protein.
Key facts
INN lonoctocog alfa
Brand AFSTYLA
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is lonoctocog alfa?
lonoctocog alfa (AFSTYLA) is a coagulation factor viii exogenous protein.
What is the brand name for lonoctocog alfa?
AFSTYLA is a marketed brand name for lonoctocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.